1142095-93-9
Chemical Structure
Etravirine-d4
Synonym(s): TMC-125 d4;R-165335 d4
- CAS No.: 1142095-93-9
- Formula:C20H11D4BrN6O
- Molecular Weight:439.30
IUPAC Name: 4-((4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)benzonitrile-2,3,5,6-d4
InChIKey: PYGWGZALEOIKDF-LNFUJOGGSA-N
SMILES: NC1=C(Br)C(OC2=C(C)C=C(C#N)C=C2C)=NC(NC3=C([2H])C([2H])=C(C#N)C([2H])=C3[2H])=N1
Biological Activity: Etravirine-d4 is the deuterium labeled Etravirine. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Etravirine-d4 | 98.31% | Etravirine-d4 is the deuterium labeled Etravirine. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine (Standard) | ≥98% | Etravirine (Standard) is the analytical standard of Etravirine. This product is intended for research and analytical applications. Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine-d8 | Etravirine-d8 is the deuterium labeled Etravirine. Etravirine (R165335) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine-13C3 | Etravirine-13C3 (R165335-13C3) is the 13C-labeled Etravirine (HY-90005). Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine | 99.07% | Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||